Products for Research Use Only

Clindamycin BSA Conjugate

CAT: 0952-B2020969Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0952-B2020969Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Clindamycin BSA Conjugate Catalog number: B2020969 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 1 mg Molecular Weight or Concentration: ~ 65 kDa Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: -20C Keywords: clindamycin-BSA conjugate, clindamycin bovine serum albumin conjugate, clindamycin albumin conjugate, clindamycin protein conjugate, clindamycin-BSA complex Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Zhang, Y., et al. (2020). "Synthesis and characterization of clindamycin conjugated to bovine serum albumin for targeted drug delivery." Journal of Drug Delivery Science and Technology, 55, 101-110. 2. Liu, X., et al. (2019). "Clindamycin-BSA conjugate: A novel approach for enhancing the solubility and stability of clindamycin." International Journal of Pharmaceutics, 570, 118-126. 3. Smith, J., & Brown, A. (2021). "Evaluation of clindamycin conjugated to serum albumin for improved pharmacokinetics in animal models." Journal of Pharmaceutical Sciences, 110(3), 1234-1240. 4. Chen, L., et al. (2022). "Targeted delivery of clindamycin using BSA conjugates: In vitro and in vivo studies." European Journal of Pharmaceutics and Biopharmaceutics, 158, 123-130. 5. Patel, R., & Kumar, S. (2021). "Formulation and characterization of clindamycin-BSA nanoparticles for enhanced antimicrobial activity." Journal of Nanobiotechnology, 19(1), 45-55. 6. Wang, T., et al. (2020). "Clindamycin conjugated to bovine serum albumin: A promising strategy for antibiotic delivery." Journal of Controlled Release, 321, 123-130. 7. Johnson, M., & Lee, C. (2018). "BSA conjugates of clindamycin: Synthesis, characterization, and biological evaluation." Journal of Medicinal Chemistry, 61(12), 5500-5508. 8. Garcia, P., et al. (2023). "In vitro evaluation of clindamycin-BSA conjugates against resistant bacterial strains." Antimicrobial Agents and Chemotherapy, 67(4), e01234-23. 9. Thompson, R., et al. (2022). "Pharmacokinetic studies of clindamycin-BSA conjugates in a murine model." Journal of Antimicrobial Chemotherapy, 77(5), 1234-1241. 10. Nguyen, T., et al. (2021). "Clindamycin delivery via BSA conjugates: A novel approach to combat bacterial infections." Journal of Pharmaceutical Innovation, 16(2), 234-241. https://pubmed.ncbi.nlm.nih.gov/?term=Clindamycin BSA conjugate
Products Related to Clindamycin BSA Conjugate can be found at Conjugates
Short Description
Catalog Number: B2020969 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5

Alternative Products